Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017;42(1):73-77.
doi: 10.5114/ceji.2017.67320. Epub 2017 May 8.

Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer

Affiliations

Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer

Ahmet Mentese et al. Cent Eur J Immunol. 2017.

Abstract

Cancer is the second leading cause of death and gastric cancer is the fourth most common cancer type worldwide. Investigation of autoantibodies in cancer patients has been a popular research area in recent years. The aim of the current study was to investigate carbonic anhydrase I and II (CA I and II) autoantibodies in the plasma of subjects with gastric cancer based on the information and considerations of autoimmune relation of gastric cancer. Anti-CA I and II antibody levels were investigated by ELISA in plasma samples of fifty two patients with gastric cancer and thirty five healthy peers. Anti-CA I and II antibody titers of the gastric cancer group were significantly higher compared with the control group (p = 0.004, p = 0.0001, respectively). Plasma anti-CA I levels of the metastatic group were lower than the non-metastatic group and this difference was found statistically significant (p < 0.05), but there was no statistical difference between plasma anti-CA II levels of the groups. CA I and II autoantibody titers in patients with gastric cancer were found higher compared to healthy subjects and the results suggest that these autoantibodies may be involved in the pathogenesis of gastric cancer.

Keywords: Helicobacter pylori; autoantibody; carbonic anhydrase; gastric cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Anti-CA I antibodies in plasma from patients with GC and healthy controls. The dotted line indicates the mean value + 3SD of healthy control plasma (A480 = 0.479)
Fig. 2
Fig. 2
Anti-CA II antibodies in plasma from patients with GC and healthy controls. The dotted line indicates the mean value +3 SD of healthy control plasma (A480 = 0.291)
Fig. 3
Fig. 3
ROC curve analysis of CA I autoantibody values in patients with GC
Fig. 4
Fig. 4
ROC curve analysis of CA II autoantibody values in patients with GC

References

    1. Abu-Shakra M, Buskila D, Ehrenfeld M, et al. Cancer and autoimmunity: Autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis. 2001;60:433–441. - PMC - PubMed
    1. Ortona E, Pierdominici M, Berstein L. Autoantibodies to estrogen receptors and their involvement in autoimmune diseases and cancer. J Steroid Biochem Mol Biol. 2014;144:260–267. - PubMed
    1. Chapman CJ, Murray A, McElveen JE, et al. Autoantibodies in lung cancer: Possibilities for early detection and subsequent cure. Thorax. 2008;63:228–233. - PubMed
    1. Zhong L, Ge K, Zu JC, et al. Autoantibodies as potential biomarkers for breast cancer. Breast Cancer Res. 2008;10:R40. - PMC - PubMed
    1. Lowe FJ, Shen W, Zu J, et al. A novel autoantibody test for the detection of pre-neoplastic lung lesions. Mol Cancer. 2014;13:78. - PMC - PubMed